BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 29031204)

  • 1. Ginkgetin inhibits growth of breast carcinoma via regulating MAPKs pathway.
    Cao J; Tong C; Liu Y; Wang J; Ni X; Xiong MM
    Biomed Pharmacother; 2017 Dec; 96():450-458. PubMed ID: 29031204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.
    Chun J; Kim YS
    Chem Biol Interact; 2013 Oct; 205(3):212-21. PubMed ID: 23867902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
    Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ω-hydroxyundec-9-enoic acid induces apoptosis by ROS mediated JNK and p38 phosphorylation in breast cancer cell lines.
    Ahn J; Chung YW; Park JB; Yang KM
    J Cell Biochem; 2018 Jan; 119(1):998-1007. PubMed ID: 28681938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoobtusilactone A induces cell cycle arrest and apoptosis through reactive oxygen species/apoptosis signal-regulating kinase 1 signaling pathway in human breast cancer cells.
    Kuo PL; Chen CY; Hsu YL
    Cancer Res; 2007 Aug; 67(15):7406-20. PubMed ID: 17671211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asiatic acid, a triterpene, induces apoptosis and cell cycle arrest through activation of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways in human breast cancer cells.
    Hsu YL; Kuo PL; Lin LT; Lin CC
    J Pharmacol Exp Ther; 2005 Apr; 313(1):333-44. PubMed ID: 15626723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ginkgetin inhibits proliferation of human leukemia cells via the TNF-α signaling pathway.
    Pan LL; Wu WJ; Zheng GF; Han XY; He JS; Cai Z
    Z Naturforsch C J Biosci; 2017 Oct; 72(11-12):441-447. PubMed ID: 28902633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABL-N-induced apoptosis in human breast cancer cells is partially mediated by c-Jun NH2-terminal kinase activation.
    Liu B; Han M; Sun RH; Wang JJ; Zhang YP; Zhang DQ; Wen JK
    Breast Cancer Res; 2010; 12(1):R9. PubMed ID: 20096139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Annosquacin B induces mitochondrial apoptosis in multidrug resistant human breast cancer cell line MCF-7/ADR through selectively modulating MAPKs pathways.
    Yuan F; Bai G; Miao Y; Chen Y; Li X; Chen J
    Pharm Biol; 2016 Dec; 54(12):3040-3045. PubMed ID: 27450387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotropin-releasing hormone type II antagonist induces apoptosis in MCF-7 and triple-negative MDA-MB-231 human breast cancer cells in vitro and in vivo.
    Gründker C; Föst C; Fister S; Nolte N; Günthert AR; Emons G
    Breast Cancer Res; 2010; 12(4):R49. PubMed ID: 20630060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ginkgetin inhibits the growth of DU-145 prostate cancer cells through inhibition of signal transducer and activator of transcription 3 activity.
    Jeon YJ; Jung SN; Yun J; Lee CW; Choi J; Lee YJ; Han DC; Kwon BM
    Cancer Sci; 2015 Apr; 106(4):413-20. PubMed ID: 25611086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The flavonoid TL-2-8 induces cell death and immature mitophagy in breast cancer cells via abrogating the function of the AHA1/Hsp90 complex.
    Liu HJ; Jiang XX; Guo YZ; Sun FH; Kou XH; Bao Y; Zhang ZQ; Lin ZH; Ding TB; Jiang L; Lei XS; Yang YH
    Acta Pharmacol Sin; 2017 Oct; 38(10):1381-1393. PubMed ID: 28504248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tunicamycin potentiates paclitaxel-induced apoptosis through inhibition of PI3K/AKT and MAPK pathways in breast cancer.
    Huang S; Wang D; Zhang S; Huang X; Wang D; Ijaz M; Shi Y
    Cancer Chemother Pharmacol; 2017 Oct; 80(4):685-696. PubMed ID: 28779263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel synthetic triterpenoid methyl 25-hydroxy-3-oxoolean-12-en-28-oate induces apoptosis through JNK and p38 MAPK pathways in human breast adenocarcinoma MCF-7 cells.
    Rabi T; Banerjee S
    Mol Carcinog; 2008 Jun; 47(6):415-23. PubMed ID: 18058803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tanshinone IIA inhibits gastric carcinoma AGS cells through increasing p-p38, p-JNK and p53 but reducing p-ERK, CDC2 and cyclin B1 expression.
    Su CC
    Anticancer Res; 2014 Dec; 34(12):7097-110. PubMed ID: 25503137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of stress activated protein kinases (JNK and p38) in 1,25 dihydroxyvitamin D3-induced breast cell death.
    Brosseau CM; Pirianov G; Colston KW
    Steroids; 2010 Dec; 75(13-14):1082-8. PubMed ID: 20654640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: therapeutic implications for prostate cancer.
    Joo SS; Yoo YM
    J Pineal Res; 2009 Aug; 47(1):8-14. PubMed ID: 19522739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental study on suppressive effect of zilongjin on growth of human breast cancer cell line MCF-7 in vitro and in vivo].
    Tian ZH; Liang YY; Li ZF
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Dec; 30(12):1292-6. PubMed ID: 21302494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein tyrosine kinase, JNK, and ERK involvement in pseudolaric acid B-induced apoptosis of human breast cancer MCF-7 cells.
    Yu JH; Wang HJ; Li XR; Tashiro S; Onodera S; Ikejima T
    Acta Pharmacol Sin; 2008 Sep; 29(9):1069-76. PubMed ID: 18718176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells.
    Li JP; Yang YX; Liu QL; Zhou ZW; Pan ST; He ZX; Zhang X; Yang T; Pan SY; Duan W; He SM; Chen XW; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1027-62. PubMed ID: 25733818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.